Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
Ionis Pharmaceuticals’ $575 Million Convertible Senior Notes Offering
RTW’s $125 Million Investment in Milestone Pharmaceuticals
Gibson Dunn acted as legal advisor to RTW, and Cooley acted as legal advisor to Milestone. Milestone Pharmaceuticals Inc. announced that it has entered into a...
Carlyle and Abingworth’s $170 Million Non-dilutive Financing of Opthea
Goodwin Procter and Debevoise & Plimpton advised Carlyle on the deal, while Cooley and Gilbert+Tobin advised Opthea. Global investment firm Carlyle and its life sciences franchise...
Unilever’s Acquisition of a Majority Stake in Nutrafol
Cravath, Swaine & Moore represented Unilever in the transaction while Cooley advised Nutrafol. Unilever, one of the world’s leading suppliers of Beauty & Personal Care, Home...